Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03386136 · ClinicalTrials.gov registry record · Phase 1

Therapeutic Oxygen for Gastrointestinal Atony (TOGA)

A Phase 1 study, sponsored by University of Florida.

Completed
Registry status
Phase 1
Development phase
17
Enrollment target

NCT03386136 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 17 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03386136, a Phase 1 study, has completed, sponsored by University of Florida.

COMPLETED
Registry status
Phase 1
Development phase
17 participants
Enrollment target

Study Summary

This study is a non invasive study to see if 100% oxygen therapy will help to resolve an intestinal obstruction.

Interventions

  • DRUG 100% Oxygen

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2018-01-25
Est. Completion 2019-10-17
Phase Phase 1

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT03386136

The ClinicalTrials.gov registry entry for NCT03386136 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which 100% Oxygen is the first listed.

NCT03386136 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03386136 about?

NCT03386136 is a clinical study titled "Therapeutic Oxygen for Gastrointestinal Atony (TOGA)". This study is a non invasive study to see if 100% oxygen therapy will help to resolve an intestinal obstruction.

What is the current status of trial NCT03386136?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2018-01-25. Estimated completion is 2019-10-17.

What interventions are being tested in trial NCT03386136?

The interventions under investigation include: 100% Oxygen (DRUG).

Who is sponsoring clinical trial NCT03386136?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.